XETRA - Delayed Quote • EUR Fresenius Medical Care AG (FME.DE) Follow Compare 43.55 +0.12 +(0.28%) As of 1:16:44 PM GMT+1. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Zacks Value Investor Highlights: Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care have been highlighted in this Value Investor article. 5 Classic Value Stocks for 2025 These stocks are cheap and have top Zacks Ranks of Strong Buy or Buy. Fresenius Medical price target raised to $25 from $23 at Truist Truist raised the firm’s price target on Fresenius Medical (FMS) to $25 from $23 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. Selectivity is k Best Value Stocks to Buy for January 7th FMS, SVM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 7, 2024. Best Momentum Stocks to Buy for December 27th PAYO, TTDKY and FMS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 27, 2024. Best Value Stocks to Buy for December 27th AAL, FMS and TTDKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 27, 2024. Is Now The Time To Look At Buying Fresenius Medical Care AG (ETR:FME)? Let's talk about the popular Fresenius Medical Care AG ( ETR:FME ). The company's shares saw a significant share price... Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run? AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has been recognized as a sustainability leader with the inclusion in the Dow Jones Sustainability World Index and with the inclusion in the Dow Jones Sustainability Europe Index for the 15th time. Dow Jones Sustainability Index (DJSI) is one of the world's leading ESG (Environmental, Social, Governance) stock indices. Fresenius Medical Care returns to Dax 40 Index Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, will return to the top tier of the German Stock Index, the DAX 40, as of December 27, 2024. The index represents the performance of the 40 largest publicly traded companies listed on the Frankfurt Stock Exchange and accounts for around 80 percent of the market capitalization of listed stock corporations in Germany. Zacks.com featured highlights Tyson Foods, General Motors, Fresenius Medical Care and Deluxe Tyson Foods, General Motors, Fresenius Medical Care and Deluxe have been highlighted in this Screen of The Week article. 4 Value Stocks to Buy as Wall Street Awaits Fed's Rate Decision Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. TSN, GM, FMS and DLX boast a low P/CF ratio. Leadership in Dialysis Services and Products Drives FMS Stock Fresenius Medical Care leads global dialysis services, driving growth through innovation, restructuring and a strong global footprint in 120+ countries. Institutional investors control 42% of Fresenius Medical Care AG (ETR:FME) and were rewarded last week after stock increased 6.1% Key Insights Given the large stake in the stock by institutions, Fresenius Medical Care's stock price might be... Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Tactile Systems Technology, Inc. (TCMD) Hit a 52 Week High, Can the Run Continue? Tactile Systems Technology (TCMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. Fresenius Medical Care AG's (ETR:FME) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock? Fresenius Medical Care's (ETR:FME) stock is up by a considerable 20% over the past three months. We, however wanted to... Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO System Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced its heart and lung group has been awarded a national group purchasing agreement for Mechanical Circulatory Support with Premier, Inc in the U.S. Since acquiring Xenios in 2016, Fresenius Medical Care has been dedicated to advancing heart and lung therapy. The agreement underscores FME's commitment to critical care solutions and allows Premier member hospitals a Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Performance Overview Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is DAX P Return FME.DE DAX P YTD -1.38% +1.78% 1-Year +22.22% +21.31% 3-Year -18.39% +26.40%